Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 71335-9705

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 71335-9705). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
A chart showing pharmacokinetic fold changes and 90% confidence interval recommendations for venlafaxine when co-administered with various interacting drugs. The x-axis presents the change relative to the reference value for parameters including Cmax and AUC of venlafaxine and its ODV metabolite. The chart lists interacting drugs such as ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium, with guidance such as dose adjustments or cautions noted alongside each.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A pharmacokinetic chart displaying the PKFold change and 90% confidence intervals for various interacting drugs and their analytes in relation to Venlafaxine Hydrochloride. The graph compares Cmax and AUC values for drugs including ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, desipramine, haloperidol, caffeine, tolbutamide, and lithium with recommendations noted for dose adjustments or clinical significance.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A scatter plot chart illustrating pharmacokinetic changes in venlafaxine hydrochloride (Cmax, AUC) across special populations, including hepatic and renal impairments, CYP2D6 metabolizer status, age, and gender. The x-axis represents change relative to the reference value, with dose adjustment recommendations listed for each condition.*
FDA Label Image

Label (Lbl713359705)

Label (Lbl713359705)
Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP, 37.5 mg, containing 30 capsules. The label includes storage instructions, child-resistant packaging notes, and directs dispensing of the medication guide. It shows the NDC 71335-9705-1 and indicates the product is repackaged by Bryant Ranch Prepack and manufactured by Yichang Humanwell Oral Solid Dosage Plant.*
FDA Label Image

Structural Formula For Venlafaxine Hydrochloride (Structure)

Structural Formula For Venlafaxine Hydrochloride (Structure)
Chemical structure diagram of venlafaxine hydrochloride showing its molecular arrangement, including functional groups and aromatic ring, labeled with the compound name venlafaxine hydrochloride.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.